Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Viasat Director Stenbit Files Form 4 on Stock Option Exercise

John P. Stenbit, a director of Viasat Inc. (NASDAQ:VSAT), filed a Form 4 on September 3, 2026, reporting transactions dated September 1, 2026, involving the exercise of a stock option and a subsequent sale of common shares under a Rule 10b5-1 plan.

Vinay Lochav | 03 September 2026

SEI Investments Director Exercises Options, Sells 5,000 Shares

Director Carmen Romeo filed a Form 4 with the SEC on September 3, 2026, reporting the exercise of stock options and the sale of 5,000 shares of SEI Investments Co common stock on September 1, 2026.

Shwetambri Chauhan | 03 September 2026

Alkami Technology CLO Discloses RSU Tax Withholding Sale

Douglas A. Linebarger, Chief Legal Officer of Alkami Technology, Inc., filed a statement of changes in beneficial ownership on September 3, 2026, reporting a share disposal transaction dated September 1, 2026.

Anjali Anand | 03 September 2026

United Therapeutics CEO Sells Shares Under 10b5-1 Plan

Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corp (NASDAQ:UTHR), filed a Form 4 on September 3, 2026, disclosing the exercise of stock options and sale of common stock on September 2, 2026, pursuant to a pre-arranged Rule 10b5-1 trading plan.

Nitish Kishor | 03 September 2026

Alkami Technology CAO Reports RSU Tax Withholding Sale

Prerna Sachdeva, Chief Accounting Officer of Alkami Technology, Inc., filed a Form 4 on September 3, 2026, disclosing the disposition of shares of common stock on September 1, 2026, in connection with the vesting and settlement of restricted stock units.

Nitish Kishor | 03 September 2026

United Therapeutics EVP Sells Shares After Option Exercise

Paul A. Mahon, Executive Vice President and General Counsel of United Therapeutics Corporation, filed a Form 4 on September 3, 2026, disclosing the exercise of stock options and the sale of resulting common stock shares pursuant to a pre-arranged Rule 10b5-1 plan.

Shwetambri Chauhan | 03 September 2026

Regeneron Director Guarini Exercises Options, Sells 400 Shares

Director Kathryn Guarini filed a Form 4 with the SEC on September 3, 2026, disclosing transactions in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) common stock dated September 2, 2026.

Vinay Lochav | 03 September 2026

Cathay General Bancorp Director Sells 1,000 Shares

Richard Sun, a director of Cathay General Bancorp, filed a statement of changes in beneficial ownership on September 3, 2026, disclosing a sale of 1,000 shares of common stock on September 2, 2026.

Aditi Sarkar | 03 September 2026

Regeneron EVP Marion McCourt Sells Shares in Two Transactions

Marion McCourt, Executive Vice President Commercial of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), filed a Form 4 on September 3, 2026, reporting the sale of common stock on September 2 and September 3, 2026, pursuant to a Rule 10b5-1 plan.

Shwetambri Chauhan | 03 September 2026

Qualys CFO Sells 1,030 Shares Under 10b5-1 Plan

Qualys, Inc. Chief Financial Officer Joo Mi Kim filed a Form 4 on September 3, 2026, disclosing the sale of 1,030 shares of common stock on September 2, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Nitish Kishor | 03 September 2026
Support

Hi! How can we help you today?

Loading…